IPM Magazine

Volume 09, Issue No. 4, August 2022

Complacency leads to vulnerability. As a species we have always been susceptible to microbial attacks, for centuries we’ve played a game of cat and mouse as we‘ve co-existed with a challenging nemesis. SARS-CoV-2 has laid bare many shortcomings, not least the inequities of global resources and opportunities. But there is cause for optimism. We hear from some of the individuals working in the infectious disease ecosystem who are committed to building the necessary foundations and implementing the requisite methodologies to deal with these viral invaders. Whether it is in the field of biosecurity, surveillance, data modelling, vaccine research, therapeutic and diagnostic development – the world needs to coalesce and develop a coordinated approach across all disciplines and across all borders. As William Haseltine aptly sums up in his column, the question isn’t whether it’s achievable, it’s whether there is the political will to do it.

Damian Doherty

Editor in Chief

Browse the print magazine as a flipbook

Website Content from This Issue

Genomic Pathogen Surveillance in the Spotlight

Quadrum Institute lab photo

Data Rules: Looking Inside the Pandemic Prevention Institute with Kaitlyn Johnson


Fighting Antibiotic Resistance with Biology


Protecting Patient Privacy

Data Medicine

The Path to the Healthcare of Tomorrow

Man walking in opposite direction of arrow

Aiming Precision Medicine at Chronic Diseases

Finger Prick

Electronic Health Records and Genomic Data – Not Yet a Perfect Match

Electronic Health Records illustration

A Field Guide to Mapping the Tumor Microenvironment with Spatial Transcriptomics in Complex Samples

Cell division

Deep Data and Precision Health

Data scientist illustration

Using AI to Improve Chronic Disease Outcomes

Robot taking woman's blood pressure

These Six Biotechs are Winning the Race to Get AI-Designed Drugs to the Clinic

graphic of the number six

Asked and Answered: Jonathan Thon Talks about Bringing Gene Therapy to Life

Jonathan Thon with colleagues

In Conversation with Renee Wegrzyn

Ginkgo’s biosecurity business

entrePRECISIONeur: Sudhakaran Prabakaran Discusses Discoveries in the Dark Regions of the Genome

Sudhakharan Prabakaran

Controlling COVID-19: What Can We Learn From Previous Pandemics?

William Haseltine

Relatively Speaking: COVID-19’s Impact on Cancer Screenings and Genetic Counseling Services

digital heads

The End of Medicine as We Know it – And Why Your Health Has a Future

The End of Medicine as We Know it — And Why Your Health Has a Future book cover

CDMO Services: Enabling Faster Time to Results and Market


AI Applications for Clinical Development: From Identifying Patients to Amplifying Trial Endpoints


Bringing Antibody-Drug Conjugates into the Precision Era

3D Rendering of Antibody Drug Conjugate Molecules
Inside Precision Medicine